Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • For a short-term investment strategy, the company has poor fundamentals.
Strengths
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
  • One of the major weak points of the company is its financial situation.
  • The group usually releases earnings worse than estimated.
  • The company's enterprise value to sales, at 4.86 times its current sales, is high.
  • The company benefits from high valuations in earnings multiples.
  • The company is not the most generous with respect to shareholders' compensation.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart
Sector Medical Supplies
1st jan.Capitalisation (M$)Investor Rating
BECTON, DICKINSON AND COMPA..-5.85%69 439
COLOPLAST A/S18.59%30 446
TELEFLEX INCORPORATED4.97%18 293
SHANDONG WEIGAO GROUP MEDIC..5.14%5 715
HARTALEGA HOLDINGS BERHAD--.--%4 796
TOP GLOVE CORPORATION BERHA..--.--%3 340
SHANDONG PHARMACEUTICAL GLA..29.96%2 936
KOSSAN RUBBER INDUSTRIES BE..--.--%1 413
HOGY MEDICAL CO.,LTD.-6.12%898
ADVANCED MEDICAL SOLUTIONS ..-5.41%779
NAGAILEBEN CO., LTD.-0.98%689
RIVERSTONE HOLDINGS LIMITED9.78%537
SUPERMAX CORPORATION BERHAD--.--%502
CI MEDICAL CO LTD--.--%254
More Results
Financials (USD)
Sales 2020 17 681 M
EBIT 2020 4 552 M
Net income 2020 2 198 M
Debt 2020 16 514 M
Yield 2020 1,38%
P/E ratio 2020 30,3x
P/E ratio 2021 23,0x
EV / Sales2020 4,86x
EV / Sales2021 4,47x
Capitalization 69 439 M
Upcoming event on BECTON, DICKINSON AND COMP
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes